2024 Research Portfolios Now Available
BrightFocus Foundation’s 2024 research portfolios highlight the active biomedical research projects the Foundation is supporting across the globe to advance cures for Alzheimer’s disease, macular degeneration, and glaucoma.
These projects are rigorously selected by a committee of world-renowned scientists who serve on the Foundation’s Scientific Review Committees to reflect the most innovative and promising ideas that will advance our understanding of these diseases of mind and sight.
BrightFocus is deeply grateful to its donors, whose generosity empowers the next generation of researchers to pursue innovative, bold, and promising science, bringing us closer to novel treatments, prevention strategies, and cures for Alzheimer’s disease, macular degeneration, and glaucoma.
Alzheimer’s Disease Research
Alzheimer’s Disease Research is supporting 112 grants examining the disease’s onset, progression, and treatments.
View the Alzheimer’s Disease Research Portfolio in magazine format or view a printable format (PDF).
Macular Degeneration Research
Macular Degeneration Research is supporting 49 grants exploring the root causes and potential prevention, treatment, and cure of macular degeneration.
View the Macular Degeneration Research Portfolio in magazine format or view a printable format (PDF).
National Glaucoma Research
National Glaucoma Research is supporting 38 grants exploring the root causes and prevention strategies and treatments to end glaucoma.
View the National Glaucoma Research Portfolio in magazine format or view a printable format (PDF).
About BrightFocus Foundation
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs — Alzheimer’s Disease Research, National Glaucoma Research, and Macular Degeneration Research — the Foundation has awarded nearly $300 million in groundbreaking research funding over the past 51 years and shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Related:
BrightFocus Foundation’s 2024 annual report highlights groundbreaking research and public awareness efforts over the last year to defeat Alzheimer’s disease, macular degeneration, and glaucoma.
Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer’s disease, macular degeneration, and glaucoma research grant funding—age-related diseases with no cure that affect more than 335 million people worldwide.
Donate to Cure Diseases of Mind and Sight
Support groundbreaking research worldwide to end Alzheimer’s disease, age-related macular degeneration, and glaucoma.
Don't miss out.
Receive breakthrough news, research updates, and expert advice on Alzheimer's disease, macular degeneration, and glaucoma.